Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Edwards
Joanne
J
Leung
Hing Y
HY
D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D011471:Prostatic Neoplasms / Q000737:chemistry* / Q000473:pathology; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000032:analysis*; D014362:Trypsinogen / Q000502:physiology
D014359:Trypsin Inhibitor, Kazal Pancreatic; D014362:Trypsinogen